REGEN-COV is authorized for emergency use by FDA for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including
Member Since 1 Year
Nature of Business Manufacturer
GST No. 27AACCU3203E1ZT
For Buyer 
For Seller 
Help 
Piramal Nagar, Mumbai, Maharashtra 
Send Enquiry